Diagnostics News and Research

RSS

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.

8 Nov 2012

Atherotech VAP Lipid Panel demonstrates accuracy in personalized heart disease risk assessment

Researchers using the Atherotech VAP Lipid Panel demonstrated the comprehensive lipid profile's accuracy in risk stratification through subclass measurement in two abstracts presented today at the American Heart Association (AHA) Scientific Sessions 2012.

8 Nov 2012

University of Tübingen heads Neuromics consortium

Work has begun on Neuromics, a major project headed by Tübingen's Professor Olaf Riess; the project beat out ten other first-class applications to attain €12m euros in EU funding over five years.

8 Nov 2012

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

Physicians - attendees of the 25th Annual EANM (European Association of Nuclear Medicine) Congress (October 27-31, Milan) - expressed their continuing interest in and recognition for Tektrotyd, a radiopharmaceutical responsible for significant progress in diagnostics/therapy of neuroendocrine tumours.

8 Nov 2012

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Today sees the launch of the International Diagnostics Centre (IDC), a global research collaboration hub, created at the London School of Hygiene & Tropical Medicine to undertake innovative research on the development and deployment of new diagnostic tests that enable patients to be diagnosed faster, more accurately and cost effectively.

8 Nov 2012

Ion AmpliSeq Community Panels from Life Technologies

Life Technologies Corporation today announced Ion AmpliSeq Community Panels, a community-driven solution to gene panel sequencing that leverages the expertise of scientific thought leaders and the Ion Community to create gene panels for conditions ranging from cancer to inherited diseases.

7 Nov 2012

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

Texas Biomedical Research Institute scientists in San Antonio have developed a faster, less expensive route to screen suitable tests for bioterror threats and accelerate the application of countermeasures.

7 Nov 2012

LipoScience presents key findings related to LDL-P and CVD at AHA annual meeting

LipoScience, Inc., an in vitro diagnostic company committed to advancing patient care in cardiovascular, metabolic and other diseases, today presented key findings related to lipoprotein particles (LDL-P) and cardiovascular disease at the Annual Meeting of the American Heart Association (AHA) in Los Angeles.

7 Nov 2012

Comprehensive overview of vascular risk factors to Alzheimer's disease

Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer's disease.

6 Nov 2012

USAID newsletter focuses on TB

The November 2012 issue of USAID's "Global Health News" newsletter focuses on tuberculosis (TB).

6 Nov 2012

Affymetrix reports net loss of $17.9 million for third quarter 2012

Affymetrix, Inc., today reported its operating results for the third quarter of 2012. Total revenue for the quarter was $79.6 million, including approximately $17.6 million in revenue from eBioscience during the third quarter of 2012. This compares to total revenue of $64.0 million for the same period of 2011.

5 Nov 2012

SpinChip aims to help doctors analyse patients' blood samples on the spot

The Norwegian company SpinChip aims to help doctors analyse patients' blood samples on the spot and provide immediate results.

5 Nov 2012

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Pressure BioSciences, Inc. today announced that scientists from two separate research groups presented data at the recent HUPO 11th Annual World Congress (Boston, MA) indicating that the incorporation of the Company's Pressure Cycling Technology Platform into their sample preparation processes resulted in a marked improvement in the quality and/or efficiency of test results.

3 Nov 2012

Sausalito Shine a Light on Lung Cancer Vigil to be held on Nov. 13 in the U.S.

This event will shine a light on one of the United States' most deadly and overlooked epidemics. Lung cancer kills approximately 160,000 Americans annually - more than breast, prostate and colon cancers combined - and has the worst survival rate of all cancers.

3 Nov 2012

GlobalPost interviews director of WHO Stop TB Department about future of global response

In an interview with GlobalPost's "Global Pulse" blog, Mario Raviglione, director of the WHO's Stop TB Department, explains "why the fight against [tuberculosis (TB)] is at a crossroads."

3 Nov 2012

Physicists to bring to market new drug-discovery tool using genetic sequencing

Today physicists at Wake Forest University and NanoMedica, their biotechnology company partner, received a $700,000 grant from the National Institutes of Health to bring to market a new drug-discovery tool using next-generation genetic sequencing.

3 Nov 2012

Virginia G. Piper, TESARO announce initiation of TSR-011 clinical trial for advanced cancer

TESARO, Inc. announced today that the first clinical trial of its proprietary Anaplastic Lymphoma Kinase (ALK) inhibitor, TSR-011, has commenced with the dosing of the first patient at the Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).

2 Nov 2012

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

Researchers from UC Irvine's Chao Family Comprehensive Cancer Center and California State University, Fullerton's Health Promotion Research Institute have formed a partnership to help reduce cancer disparities in Orange County.

2 Nov 2012

Microbiologists confirm existence of new tick disease in Switzerland

Until now, we knew that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi - which causes borreliosis - and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists from the University of Zurich confirm the existence of another tick disease in Switzerland - neoehrlichiosis.

1 Nov 2012

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.

1 Nov 2012

Diagnostics News and Research

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Atherotech VAP Lipid Panel demonstrates accuracy in personalized heart disease risk assessment

University of Tübingen heads Neuromics consortium

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

London School of Hygiene & Tropical Medicine creates International Diagnostics Centre

Ion AmpliSeq Community Panels from Life Technologies

Texas Biomed develops rapid, less expensive route to screen suitable tests for bioterror threats

LipoScience presents key findings related to LDL-P and CVD at AHA annual meeting

Comprehensive overview of vascular risk factors to Alzheimer's disease

USAID newsletter focuses on TB

Affymetrix reports net loss of $17.9 million for third quarter 2012

SpinChip aims to help doctors analyse patients' blood samples on the spot

Two research groups present data on Pressure BioSciences' PCT Platform at HUPO 2012

Sausalito Shine a Light on Lung Cancer Vigil to be held on Nov. 13 in the U.S.

GlobalPost interviews director of WHO Stop TB Department about future of global response

Physicists to bring to market new drug-discovery tool using genetic sequencing

Virginia G. Piper, TESARO announce initiation of TSR-011 clinical trial for advanced cancer

UC Irvine, Cal State Fullerton partner to help reduce cancer disparities in Orange County

Microbiologists confirm existence of new tick disease in Switzerland

Novartis resumes distribution of two seasonal influenza vaccines in Canada

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News